Loading…

CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis

Abstract The potential of lipopolysaccharide (LPS) to induce antigen-specific B cell responses to acetylcholine receptor (AChR) in myasthenia gravis (MG) was evaluated in wild type (WT) and CD4−/− C57BL/6 mice. The WT mice immunized with AChR in LPS developed an MG-like disease (LPS-EAMG) similar to...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroimmunology 2012-08, Vol.249 (1), p.1-7
Main Authors: Allman, Windy, Qi, Huibin, Saini, Shamsher S, Li, Jing, Tuzun, Erdem, Christadoss, Premkumar
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The potential of lipopolysaccharide (LPS) to induce antigen-specific B cell responses to acetylcholine receptor (AChR) in myasthenia gravis (MG) was evaluated in wild type (WT) and CD4−/− C57BL/6 mice. The WT mice immunized with AChR in LPS developed an MG-like disease (LPS-EAMG) similar to that induced by immunization with AChR in complete Freund's adjuvant (CFA-EAMG). CD4−/− mice were resistant to CFA-EAMG but susceptible to LPS-EAMG. LPS abrogated EAMG resistance in CD4−/− mice by increasing high-affinity anti-AChR IgG2b in sera and enhancing immune complex deposition in muscle.
ISSN:0165-5728
1872-8421
DOI:10.1016/j.jneuroim.2012.04.002